You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

entecavir

Showing 1 - 25 of 136
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug Trial in Seoul (Entecavir)

Enrolling by invitation
  • Hepatitis B Reactivation
  • +3 more
  • Entecavir
  • Seoul, Korea, Republic of
    Jeong Won Jang
Dec 16, 2022

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Ropeginterferon alfa-2b
  • Entecavir
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

Resolved Hepatitis B, CD20 Positive B-cell Lymphoma Trial (Entecavir)

Not yet recruiting
  • Resolved Hepatitis B
  • CD20 Positive B-cell Lymphoma
  • Entecavir
  • (no location specified)
Jul 10, 2022

Chronic Hepatitis B Trial in Shatin (Tenofovir alafenamide, Entecavir)

Not yet recruiting
  • Chronic Hepatitis B
  • Tenofovir alafenamide
  • Entecavir
  • Shatin, Hong Kong
    Prince of Wales Hospital
Jun 15, 2022

Antiviral Drugs Trial in Changsha (tenofovir alafenamide, Entecavir)

Completed
  • Antiviral Drugs
  • tenofovir alafenamide
  • Entecavir
  • Changsha, China
    Wenting Peng
Jul 10, 2022

Hepatitis B, Viral Hepatitis Trial in Taichung (Tenofovir alafenamide, Entecavir)

Recruiting
  • Hepatitis B
  • Viral Hepatitis
  • Tenofovir alafenamide
  • Entecavir
  • Taichung, Taiwan
    Taichung Veterans General Hospital
Feb 9, 2022

Hepatocellular Carcinoma Trial in Nanning (Entecavir, Tenofovir)

Recruiting
  • Hepatocellular Carcinoma
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 14, 2022

Chronic Hepatitis B Virus Infection Trial in Guangzhou (Entecavir, Entecavir combined with Tenofovir Amibufenamide)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Entecavir
  • Entecavir combined with Tenofovir Amibufenamide
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-sen University
May 15, 2022

Hepatitis B, Chronic Trial in Shanghai, Beijing (Hydronidone, Placebo, Entecavir)

Completed
  • Hepatitis B, Chronic
  • Shanghai, Shanghai, China
  • +1 more
Jun 21, 2022

Hepatitis B, Chronic Trial in Guangzhou (ASC42 10mg, ASC42 15mg, ih PEG-IFN a-2a)

Recruiting
  • Hepatitis B, Chronic
  • ASC42 10mg
  • +4 more
  • Guangzhou, Guangdong, China
    NanFang Hospital of Southern Medical University
Jan 13, 2022

Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)

Terminated
  • Hepatitis B, Chronic
  • Granulocyte Macrophage-colony Stimulating Factor
  • Entecavir
  • Beijing, Beijing, China
    302 Military Hospital
Mar 9, 2022

HCC, HBV Coinfection Trial in Chengdu (Tenofovir Disoproxil, Entecavir)

Active, not recruiting
  • HCC
  • HBV Coinfection
  • Tenofovir Disoproxil
  • Entecavir
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
May 23, 2022

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

Chronic Hepatitis b Trial in Hong Kong (RBD1016, Placebo, Entecavir)

Recruiting
  • Chronic Hepatitis b
  • Hong Kong, China
    The University of Hong Kong
Apr 24, 2022

Chronic Hepatitis B Trial in Worldwide (ALG-000184, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Guangzhou, Guangdong, China
  • +5 more
Nov 17, 2022

Stopping Antiviral Treatment in Chronic Hepatitis B

Recruiting
  • Chronic Hepatitis b
  • Entecavir
  • Hong Kong, Please Select One ..., Hong Kong
    Man Fung Yuen
Sep 28, 2021

B-cell Lymphoma, HBV Trial in Shanghai (Tenofovir, Entecavir)

Recruiting
  • B-cell Lymphoma
  • HBV
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Sep 2, 2020

Hepatitis B, Liver Cirrhosis Trial in China (Entecavir)

Active, not recruiting
  • Hepatitis B
  • Liver Cirrhosis
  • Entecavir
  • Beijing, Beijing, China
  • +19 more
Apr 25, 2021

Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

Completed
  • Chronic Hepatitis C Infection
  • +2 more
  • Hong Kong, Hong Kong, China
    Humanity and Health GI and Liver Centre
Aug 27, 2021

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

Recruiting
  • Hepatitis B, Chronic
  • Vancouver, British Columbia, Canada
  • +31 more
Jan 17, 2023

Portal Hypertension Trial in Shanghai (Entecavir, Entecavir + Fuzheng Huayu)

Unknown status
  • Portal Hypertension
  • Entecavir
  • Entecavir + Fuzheng Huayu
  • Shanghai, China
  • +2 more
Feb 11, 2020

Pediatric Immuno-Tolerant Chronic Hepatitis B Trial in Worldwide (Entecavir, Lamivudine, Pegylated Interferon Alfa-2A)

Completed
Has Results
  • Pediatric Immuno-Tolerant Chronic Hepatitis B
  • Entecavir
  • +2 more
  • Kansas City, Missouri
  • +24 more
Aug 21, 2020

Hepatitis B, Chronic Trial in Worldwide (EYP001a, Placebo, Entecavir)

Active, not recruiting
  • Hepatitis B, Chronic
  • Brisbane, Australia
  • +17 more
May 12, 2021

Entecavir for Decompensated HBV Cirrhosis

Completed
  • Hepatitis B
  • Liver Cirrhosis
  • Entecavir
  • Lucknow, UP, India
    Sanjay Gandhi Postgraduate Institute of Medical Sciences
Sep 23, 2019

Hepatitis B Infection, Malignant Solid Tumor Trial in Guam, United States (Best Practice, Entecavir, Tenofovir Alafenamide)

Recruiting
  • Hepatitis B Infection
  • Malignant Solid Neoplasm
  • Best Practice
  • +3 more
  • Fort Smith, Arkansas
  • +192 more
Apr 4, 2022